Neurology

Sunovion hires former BI exec as VP of marketing

Sunovion hires former BI exec as VP of marketing

By

Denise Strauss, formerly VP of cardiovascular marketing at Boehringer Ingelheim, will oversee the drugmaker's marketing activities.

New science drives biopharma interest in neurological conditions

New science drives biopharma interest in neurological conditions

By

The neurology market is again attracting attention and investment from various — and at times unexpected — corners of the biopharma industry.

Top 25 neurology products, based on 2016 sales forecasts

Top 25 neurology products, based on 2016 sales forecasts

MS drugs top the list, led by Teva's Copaxone, Biogen's Tecfida and Avonex, and Novartis' Gilenya.

If Roche's Ocrevus is approved, the already competitive MS market will gain another player

If Roche's Ocrevus is approved, the already competitive MS market will gain another player

By

The experimental therapy is positioned to fill a market gap in primary progressive multiple sclerosis.

EMD Serono promotes Craig Millian to SVP of neurology and immunology

EMD Serono promotes Craig Millian to SVP of neurology and immunology

By

Millian, a former Sanofi and Merck executive, on marketing new therapies in the MS market.

OPINION

Email Newsletters